James Hindman

James Hindman

Director/Board Member at ACCURAY INCORPORATED

Net worth: 111 436 $ as of 31/05/2026

65 year
Health Technology
Consumer Services
Health Services

Profile

Mr. James M.
Hindman
is an Independent Director at Urovant Sciences Ltd., an Independent Director at Accuray, Inc. and a Treasurer at Vicept Therapeutics, Inc. He is on the Board of Directors at Urovant Sciences Ltd., Accuray, Inc., Loyola Marymount University, NeuroSigma, Inc. and Aatru Medical LLC.
Mr. Hindman was previously employed as an Independent Director by Millendo Therapeutics, Inc., an Independent Director by Sienna Biopharmaceuticals, Inc., a President & Director by Allergan Foundation, and a Head-Investor Relations by Allergan, Inc. He also served on the board at Amolyt Pharma SAS, Urovant Sciences, Inc. and Millendo Therapeutics US, Inc. He received his undergraduate degree from Loyola Marymount University and an MBA from Pepperdine University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/11/2025 2,94,804 ( 0.25% ) 111 436 $ 31/05/2026

James Hindman active positions

CompaniesPositionStart
ACCURAY INCORPORATED Director/Board Member 06/09/2019
UROVANT SCIENCES LTD. Director/Board Member 20/05/2020
Treasurer -
Director/Board Member 01/02/2014
Director/Board Member 01/06/2015
Director/Board Member 01/11/2018

Former positions of James Hindman

CompaniesPositionEnd
Director/Board Member 01/07/2024
Director/Board Member 01/03/2023
MILLENDO THERAPEUTICS Director/Board Member 25/06/2021
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of James Hindman's experience

Training of James Hindman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Allergan Foundation

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology